RxDoctor Payments Data

Melissa Miao, PA

Medical · Kearny, NJNPI 1588924922

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 913 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $4,390, 4.1 times the $1,063 reported in 2021. Among medical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,760in general payments, 2019–2025

Across 913 payments — averaging $15.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • Incyte Corporation$956
  • Galderma Laboratories, L.p.$910
  • Novartis$820
  • plus $6K from 29 others

What the payments were for

  • Food & beverage$13,34297%
  • Education$4183%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,760 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.

See all medical providers in New Jersey

Medicare billing

Part B allowed, 2024
$69,528
Medicare patients
215
Services billed
1,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa12$238,614
Cosentyx Sensoready (2 Pens)Secukinumab12$88,797
Taltz AutoinjectorIxekizumab13$84,149
Fluorouracil40$2,582
Clobetasol Propionate44$2,151
Tacrolimus13$1,527
Triamcinolone Acetonide52$703
Ketoconazole54$666
CiclopiroxCiclopirox Olamine29$334
Mupirocin41$323
Ammonium Lactate13$314
Hydrocortisone28$292
Mometasone Furoate11$246

Paid to pharmacies, not to this prescriber.

Other medical in Kearny

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →